116 related articles for article (PubMed ID: 16104623)
1. [Reversible cardiogenic shock under 5-fluorouracil treatment].
Bakouboula B; Morel O; Douchet MP; Chauvin M
Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
[TBL] [Abstract][Full Text] [Related]
2. [Reversible cardiogenic shock due to 5FU. Apropos of a case report].
Dieudonne P; Dumont MA
Rev Med Brux; 1990 May; 11(5):162-6. PubMed ID: 2353140
[TBL] [Abstract][Full Text] [Related]
3. A case of cardiogenic shock caused by capecitabine treatment.
To AC; Looi KL; Damianovich D; Taylor GB; Sidebotham D; White HD
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):725-9. PubMed ID: 18813211
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
Y-Hassan S; Tornvall P; Törnerud M; Henareh L
Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
[TBL] [Abstract][Full Text] [Related]
5. Reversible cardiogenic shock following 5-fluorouracil infusion.
Ferté C; Gomez Roca C; Loriot Y; Bahleda R; Moldovan C; Cohen A; Izzedine H; Soria JC; Ederhy S
Invest New Drugs; 2010 Aug; 28(4):531-3. PubMed ID: 19499187
[TBL] [Abstract][Full Text] [Related]
6. 5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.
van Laarhoven HW; Verstappen CC; Beex LV; Kappelle AC; Punt CJ
Anticancer Res; 2003; 23(1B):647-8. PubMed ID: 12680161
[TBL] [Abstract][Full Text] [Related]
7. Use of extracorporeal membrane oxygenation for mechanical circulatory support in a patient with 5-fluorouracil induced acute heart failure.
Rateesh S; Shekar K; Naidoo R; Mittal D; Bhaskar B
Circ Heart Fail; 2015 Mar; 8(2):381-3. PubMed ID: 25783948
[No Abstract] [Full Text] [Related]
8. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy].
Rodríguez Roldán JM; Lara Alvarez MA; López Martínez J; Díaz Abad R; Caballero Campo M; Del Nogal Sáez F
Med Intensiva; 2006 Apr; 30(3):123-4. PubMed ID: 16729482
[No Abstract] [Full Text] [Related]
10. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
Hrovatin E; Viel E; Lestuzzi C; Tartuferi L; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Vaccher E; Meneguzzo N; Nicolosi GL
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):637-40. PubMed ID: 16858245
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
12. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
[TBL] [Abstract][Full Text] [Related]
13. Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report.
Kronawitter U; Kemeny NE; Blumgart L
Cancer; 1997 Aug; 80(4):656-60. PubMed ID: 9264347
[TBL] [Abstract][Full Text] [Related]
14. [Cardiogenic shock caused by 5-fluorouracil].
Mazet C; Dellinger A; Vital Durand D; Adnaoui M; Fournier G; Levrat R
Ann Cardiol Angeiol (Paris); 1990 Mar; 39(3):179-80. PubMed ID: 2344152
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
16. [Patient preference for oral chemotherapy].
Schöffski P
Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
[No Abstract] [Full Text] [Related]
17. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
Maurer U; Härle M; Jungius KP
Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
[TBL] [Abstract][Full Text] [Related]
18. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
19. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M
Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744
[TBL] [Abstract][Full Text] [Related]
20. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
Wijesinghe N
N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
